Position in REGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,870
+$1,098 QoQ
Shares Held
3
+200.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,297
of 1,322 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MOTCO holds $54,760 across 13 Biotechnology names. REGN ranks #4 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RANI |
Rani Therapeutics Holdings, Inc.
|
48,129 | $36,597 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19 | $9,437 | |
| 3 | ARGX |
Argenx SE
|
3 | $2,783 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
3 | $1,870 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
9 | $704 | |
| 6 | GMAB |
Genmab A/S
|
22 | $604 | |
| 7 | MRNA |
Moderna, Inc.
|
7 | $490 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
2 | $481 |
All Filings in REGN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,870 | 3 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $772 | 1 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $771 | 1 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $562 | 1 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $525 | 1 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $634 | 1 | Shares | Sole | 2025-05-07 | |
| 2023-12-31 | $8,782 | 10 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $8,229 | 10 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $7,185 | 10 | Shares | Sole | 2023-08-04 | |
| 2020-12-31 | $2,415 | 5 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $2,798 | 5 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $3,118 | 5 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $2,441 | 5 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||